The Skin of Color Society's Meeting the Challenge Summit, 2022: Diversity in Dermatology Clinical Trials Proceedings.

Autor:	Cobb CBC; The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Heath CR; Department of Dermatology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Byrd AS; Department of Dermatology, Howard University College of Medicine, Washington, DC.; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland., McKinley-Grant LJ; Department of Dermatology, Howard University College of Medicine, Washington, DC.; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina., Callender V; Department of Dermatology, Howard University College of Medicine, Washington, DC.; Callender Dermatology and Cosmetic Center, Washington, DC., Adamson AS; Division of Dermatology and Dermatologic Surgery, Dell Medical School at The University of Texas at Austin., Brown S 3rd; Eastern Virginia Medical School, Norfolk., Desai SR; Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas.; Innovative Dermatology, Dallas, Texas., Glass DA 2nd; Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas., Jaleel T; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina., Okoye GA; Department of Dermatology, Howard University College of Medicine, Washington, DC., Taylor SC; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York., Harvey VM; Hampton Roads Center for Dermatology, Newport News, Virginia.; Skin of Color Research Institute, Hampton University, Hampton, Virginia.
Jazyk:	angličtina
Zdroj:	JAMA dermatology [JAMA Dermatol] 2023 Jul 01; Vol. 159 (7), pp. 757-762.
DOI:	10.1001/jamadermatol.2023.1285
Abstrakt:	Importance: Clinical trials remain the cornerstone for determining the safety and efficacy of an intervention. A diverse participant pool in dermatology clinical trials is critical to ensure that results are generalizable among the patient population who will ultimately depend on the efficacy of the intervention. The Skin of Color Society hosted the inaugural Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials in Washington, DC, from June 10 to 11, 2022. The summit was an interactive and collaborative effort to advance discussions regarding the need for broader inclusion of racial and ethnic minority patients in dermatology clinical trials. Observations: The summit focused on 3 principal areas: (1) understanding the current clinical trials landscape; (2) breaking down patient, clinician, industry, and regulatory barriers; and (3) effecting change through a diversity-focused strategy. The program hosted thought-provoking panel talks and discussions with various stakeholder groups, including a keynote presentation from the family of Henrietta Lacks. Conclusions and Relevance: Panel discussions and insightful presentations from physicians, industry leaders, community trailblazers, and patients fostered new collaborations. The summit provided recommendations and suggested strategies for future initiatives designed to increase the representation of minority individuals in dermatology clinical trials.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu